POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) AND LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): INTERIM ANALYSIS OF A PHASE IB/II TRIAL
Abrisqueta, P., Kahl, B., Banerjee, L., McMillan, A., Ramchandren, R., Miall, F., Briones, J., Cordoba, R., Gonzalez-Barca, E., Panizo, C., Hirata, J., Chang, N., Musick, L., Diefenbach, C.Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000558628.70462.93
Date:
June, 2019
File:
PDF, 469 KB
2019